PUBLICATIONS

PEER REVIEWED ORIGINAL ARTICLES

  1. Nayan G Patel, Sudhesh Kumar, Margaret C Eggo. Essential Role of FGF Signalling in Pre-Adipocyte Differentiation. Journal of Clinical Endocrinology & Metabolism. September 2004 – in press.
  1. Counterweight Project Team. A new evidence-based model for weight management in primary care: The Counterweight Programme. J Hum Nutr Dietet, 2004, 17, pp 191-208.
  1. Counterweight Project Team. Current approaches to obesity management in UK Primary Care: The Counterweight Programme. J Hum Nutr Dietet, 2004, 17, pp 183-190.
  1. G. Valsamakis, R. Chetty, A. Anwar, A.K. Banerjee, A. Barnett, S. Kumar. Association of simple anthropometric measures of obesity with visceral fat and the metabolic syndrome in male caucasian and Indo-Asian subjects. Diabetic Medicinein press 2004
  1. G.Valsamakis, A. Anwar, J. Tomlinson, CHL Shackleton, PG
    McTernan, R. Chetty, AK Banerjee, G Holder, AH Barnett, PM Stewart, S.
    Kumar. 11beta hydroxysteroid dehydrogenase type 1 activity in lean and obese patients with type 2 diabetes mellitus.J Clin Endo Metab Sep 2004, 89(9): 4755-61.
  1. Valsamakis G, McTernan PG, Chetty R, Al Daghri N, Field A, Hanif W, Barnett AH, Kumar S. Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism.; April 2004 53(4):430-4.
  1. O’Hare JP, Raymond NT, Mughal S, Dodd L, Hanif W, Ahmed Y, Mishra K, Jones A, Kumar S, Szczepura A, Hillhouse EW and Barnett AH, on behalf of the UKADS study group. Re Evaluation of delivery of enhanced diabetes care to patients of South Asian ethnicity: The United Kingdom Asian Diabetes Study (UKADS).Diabetic Medicine, in press 2004.
  1. Anthony Barnett, D John Betteridge, Christopher Byrne, Nigel Capps, Robert Elkeles, Michael Feher, Gordon Ferns, Liz Hughes, Graham Jackson, Sudhesh Kumar,, Dimitri Mikhailidis, Paul Miller, Chris Packard, Vinod Patel, John Reckless, Alan Rees, Anthony Wierzbicki, Richard Wray, John Wright, Ian Young. Role of fibrates in reducing coronary risk: a UK consensus. Current Medical Research and Opinion, Vol 20 (No 2), 2004: pp 241-247.
  1. Gibbs, HD, Broom J, Brown J Laws RA, Reckless JPD, Noble PA, Kumar S, McCombie EL, Lean MEJ, Lyons GF, Frost GS, Quinn MF, Barth JH, Haynes SM, Finer N Ross HM, Hole DJ, Montazeri, A. Audit data on current GP practice for obesity management.Journal of Human Nutrition and Dietetics, in press, April 2004.
  1. Gibbs, HD, Broom J, Brown J Laws RA, Reckless JPD, Noble PA, Kumar S, McCombie EL, Lean MEJ, Lyons GF, Frost GS, Quinn MF, Barth JH, Haynes SM, Finer N Ross HM, Hole DJ, Montazeri, A. A new evidence based model for weight management in primary care: The Counterweight Programme. Journal of Human Nutrition and Dietetics,Vol 17 (No 3) June 2004, pp 191-280(18).
  1. Harte AL, McTernan PG, McTernan CL, Crocker J, Starcynski J, Barnett AH, Matyka K, Kumar S. Insulin increases angiotensinogen expression in human abdominal subcutaneous adipocytes. Diabetes Obes Metab. 2003 Nov; 5(6):462-7.
  1. Al-Daghri N, Al-Rubean K, BartlettWA, Al-Attas O, Jones AF, Kumar S. Serum leptin is elevated in Saudi Arabian patients with metabolic syndrome and coronary artery disease. Diabetic Medicine. 2003 Oct; 20(10):832-7.
  1. Harte A, McTernan P, McTernan C, Smith S, Barnett A, Kumar S. Rosiglitazone inhibits the insulin-mediated increase in PAI-1 secretion in human abdominal subcutaneous adipocytes. Diabetes, Obesity & Metabolism 2003;5:302-10.
  1. Peter P, Kumar S. Management of the overweight patient with Type 2 diabetes.Diabet Med. 2003 Sep; 20 Suppl 4:10-3.
  1. Tica V, Hanif M.W., Andersson A, Valsamakis G, Barnett A.H., Kumar S, Sanjeevi C.B. Frequency of Latent Autoimmune Diabetes in Adults in Asian Patients Diagnosed as Type 2 Diabetes in Birmingham, United Kingdom. Annals of the New YorkAcademy of Sciences: Immunology of Diabetes II, Pathogenesis from Mouse to Man2003; 1005: 356-359.
  1. Palin S, McTernan P, Anderson L.A., Sturdee D.W., Barnett A.H., Kumar S. 17-beta-estradiol and anti-estrogen ICI: compund 182,780 regulates expression of lipoprotein lipase and hormone-sensitive lipase in isolated subcutaneous abdominal adipocytes. Metabolism 2003;52:383-8.
  1. Patel N, Holder J, Smith SA, Kumar S, Eggo MC. Differential regulation of lipogenesis and leptin production by different signalling pathways and rosiglitazone during human adipocyte differentiation. Diabetes 2003; 52:43-50.
  1. Shakher A, McTernan P, Kumar S. Obesity. In Haegerty A, Tomlinson S, Weetman A, Malik R, eds. Mechanisms of Disease, Cambridge, 2003.
  1. Fisher MF, McTernan PG, Harte A, Valsamakis G, Chetty R, Barnett AH, Kumar S. Expression of adiponectin gene and protein in human adipose tissue depots: reduced expression in abdominal fat depots and in diabetes. Hormone Research & Metabolism, In press 2003.
  1. Philip G. McTernan, FFolliott M. Fisher, George Valsamakis, Rajkumar Chetty, Alison Harte, Claire L. McTernan, Penny M. S. Clark, Stephen A. Smith, Anthony H. Barnett and Sudhesh Kumar. Resistin and Type 2 Diabetes: Regulation of Resistin Expression by Insulin and Rosiglitazone and the Effects of Recombinant Resistin on Lipid and Glucose Metabolism in Human Differentiated Adipocytes. The Journal of Clinical Endocrinology & Metabolism 2003; Vol. 88, No. 12: 6098-6106.
  1. Valsamakis G, Chetty R, McTernan P, Al-Daghri N, Jones A, Kumar S. Fasting serum adiponectin concentration is reduced in Indo-Asians and is related to HDL cholesterol. Diabetes, Obesity & Metabolism 2003;5:131-5.
  1. Palin S, McTernan PG, AndersonLA, Barnett AH, Kumar S17-beta-estradiol and anti-estrogen ICI: Compound 182,780 regulates expression of lipoprotein lipase and hormone-sensitive lipase in isolated subcutaneous abdominal adipocytes. Metabolism,;52(4):383-388.
  1. McTernan PG,. Harte AL,. Andersonn LA, Green A,. Smith S A,. Holder J C,. Barnett A H,. Eggo M C and Kumar S. Insulin and Rosiglitazone Regulation of Lipolysis and Lipogenesis in Human Adipose Tissue in vitro. Diabetes 2002; 51:1493-1498
  1. AndersonAL, McTernan PG, Harte AL, Barnett AH, Kumar S. The regulation of HSL and LPL expression by DHT and Flutamide in Human Subcutaneous adipose tissue. Diabetes, Obesity & Metabolism, 2002; 4:209-214.
  1. McTernan PG, McTernan CL, Chetty R, Jenner K, Fisher fM, Lauer MN, Crocker J, Barnett AH, Kumar S. Increased Resistin Gene and Protein Expression in Human Abdominal Adipose Tissue. Journal of Clinical Endocrinology & Metabolism, 2002; 87(5):2407-2410.
  1. McTernan C.L, McTernan P.G., Harte A.L., Barnett A.H.,Kumar S. Resistin-The link between central obesity and type 2 diabetes? Lancet. 2002;359:46-7.
  2. Al-Nozha M, Al-Daghri N, Bartlett WB, Al-Maatouq M, Al-Attas O, Kumar S, Jones AF. Serum Homocysteine concentration is related to diabetes mellitus but not to coronary artery disease in a Saudi population. Diabetes, Obesity and Metabolism, 2002;4(2):118-23.
  3. McTernan P.G., Anwar A., Anderson L., Eggo M. C, Barnett A.H., Stewart P.M., Kumar S. Gender and site specific regulation of aromatase activity in human adipose tissue. J Clin Endocrinol & Metab . 2002 Mar;87(3):1327-36.
  4. Palin SL, McTernan PG, Sturdee DW, Barnett AH, Kumar S. Dydrogesterone and norethisterone regulate expression of lipoprotein lipase and hormone sensitive lipase in isolated human adipocytes. Metabolism In press 2002.
  5. Al-Daghri N, Jones AF, Bartlett B, Kumar S. Role of leptin in glucose metabolism in type 2 diabetes. Diabetes, Obesity and Metabolism, 4, 2002, 147-155.
  6. Fisher ff M, McTernan P G, Valsamakis G, Chetty R, Harte A L , Anwar A J, Starcynski J, Crocker, J, Barnett A J, McTernan C L , Kumar S. Differences in Adiponectin Protein expression: Effect of fat depots and type 2 diabetic status. Horm Metabl Res 2002: 34: 650-654.
  7. Valsamakis G, Chetty R, Kumar S. The management of obesity in type 2 diabetes mellitus. Curr Med Res and Opinion: 2002; 18(1): s75-81.
  8. Valsamakis G, Kumar S. Is sibutramine more than a slim hope? Drug and Ther Bulletin. 39(12): 89-92.